What is the follow-up schedule after ovarian cancer?

Finishing primary treatment for ovarian cancer (like surgery and chemotherapy) is a major milestone, but it is completely normal to wonder—and worry—about what comes next. A structured follow-up, or surveillance, schedule is designed to monitor your recovery, manage any lingering side effects of treatment, and watch closely for signs of recurrence. For most patients, standard surveillance guidelines recommend physical exams and CA-125 blood tests every 3 to 4 months for the first two years, and then every 6 months thereafter ^[1]. Routine imaging scans like CT or PET are generally not recommended if you feel well and your CA-125 levels remain stable ^[2][3].

It is important to note that many patients now transition directly into maintenance therapy (such as PARP inhibitors or bevacizumab) for two to three years. If you are on maintenance therapy, the line between “active treatment” and “surveillance” is blurred. Your clinic visits and blood tests (like complete blood counts) will likely be more frequent than the standard 3-to-4-month schedule to monitor how your body handles the medication.

The Standard Surveillance Timeline

Your exact follow-up plan will be personalized by your gynecologic oncologist based on the stage of your cancer, your specific tumor type (such as high-grade versus low-grade serous carcinoma), your genetic risk factors (like a BRCA mutation), and whether you are on maintenance therapy ^[4][5]. However, a standard post-treatment schedule generally looks like this:

• Years 1 and 2: Clinic visits including a physical and pelvic exam, along with a CA-125 blood test, every 3 to 4 months ^[1].
• Years 3 through 5: Clinic visits and CA-125 tests every 6 months.
• After 5 Years: Annual exams.

During these visits, your doctor will ask detailed questions about how you are feeling. Honest communication about your physical and emotional well-being is often the most important part of these appointments. You can also ask your doctor for a formal Survivorship Care Plan, which is a written document summarizing your treatments and outlining your personalized schedule for the future.

A Note on Pelvic Exams

Routine pelvic exams are a standard part of follow-up care, but they can be daunting. After major pelvic surgery, surgical menopause (if your ovaries were removed), and chemotherapy, you might experience vaginal dryness or tissue thinning (atrophy) that makes exams painful. Do not hesitate to tell your doctor this. You can request a smaller speculum, ask them to use extra lubrication, and use the opportunity to discuss treatments for vaginal discomfort.

The Role of CA-125 Blood Tests

The CA-125 test measures the level of a specific protein in your blood that is often elevated in women with ovarian cancer. If your CA-125 was elevated when you were first diagnosed, tracking it is a common way to monitor for recurrence.

However, monitoring CA-125 is a topic of ongoing discussion in the medical community. Research shows that relying only on CA-125 levels to detect disease progression is not always reliable ^[6][2]. In some cases, a patient’s CA-125 might rise before any physical symptoms appear—a situation known as biochemical recurrence. Studies have shown that starting treatment early based purely on a rising CA-125, before any symptoms or visible tumors develop, does not necessarily improve overall survival and can negatively impact a patient’s quality of life due to premature side effects from additional treatment ^[7][2]. Because of this, you and your doctor should discuss the pros and cons of routine CA-125 monitoring.

Why Routine Scans Aren’t Recommended

Many patients expect to have regular CT or PET scans to make sure the cancer hasn’t returned, and it can feel unnerving when your doctor doesn’t order them. However, professional guidelines advise against routine, scheduled imaging for asymptomatic patients ^[3].

Scans are typically reserved for specific situations:

• You develop new, unexplained symptoms.
• Your doctor feels something unusual during a physical or pelvic exam.
• Your CA-125 levels are steadily rising ^[8][9].

Skipping routine scans when you are healthy helps avoid unnecessary radiation exposure, reduces anxiety (“scanxiety”), and avoids costly medical procedures that haven’t been shown to improve survival outcomes in asymptomatic ovarian cancer survivors ^[2].

The Importance of Self-Monitoring

Because standard surveillance relies less on imaging and more on clinical evaluation, your awareness of your own body is crucial. Do not wait for your next scheduled appointment if you notice persistent changes. Contact your care team if you experience ongoing:

• Bloating or increased abdominal size
• Eating difficulty or feeling full quickly
• Abdominal or pelvic pain
• Toilet changes (changes in bowel habits or urinary urgency)

Remember, the goal of follow-up care isn’t just to look for cancer—it’s to help you transition to life after treatment, manage any lingering effects of chemotherapy or surgery (like neuropathy or fatigue), and support your overall quality of life ^[10].